Access cutting-edge advanced melanoma treatment through this clinical trial at a research site in Denver. Study-provided care at no cost to qualified participants.
Access advanced melanoma specialists in Denver at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced melanoma treatment provided free
A Phase 1/2, open-label study of a modified interleukin-2 fusion protein (IOV 3001) in participants with previously treated, unresectable or metastatic melanoma who will receive lifileucel.
Sponsor: Iovance Biotherapeutics, Inc.
Check if you qualify for this advanced melanoma clinical trial in Denver, CO
If you're searching for advanced melanoma treatment options in Denver, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Denver research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.